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UndernutritionCancer-induced cachexia describes the progressive skeletal muscle wasting associated with many cancers lead-
ing to shortened survival time in cancer patients. We previously reported that cardiolipin content and energy-
wasting processeswere both increased in livermitochondria in a ratmodel of peritoneal carcinosis (PC)-induced
cachexia. To increase the understanding of the cellular biology of cancer cachexia, we investigated the involve-
ment of adenine nucleotide translocator (ANT) inmitochondrial energy-wasting processes in liver mitochondria
of PC and pair-fed control rats and its interactions with cardiolipin in isolated liver mitochondria from healthy
rats exposed to cardiolipin-enriched liposomes. We showed in this study that functional ANT content was de-
creased in liver mitochondria from PC rats but without any effects on the efﬁciency of ATP synthesis. Moreover,
non-phosphorylating energy wasting was not affected by saturating concentrations of carboxyatractylate (CAT),
a potent inhibitor of ANT, in liver mitochondria from PC rats. Decreased efﬁciency of ATP synthesis was found in
normal liver mitochondria exposed to cardiolipin-enriched liposomes, with increased non-phosphorylating en-
ergy wasting, thus mimicking mitochondria from PC rats. However, the functional ANT content in these
cardiolipin-enriched mitochondria was unchanged, although non-phosphorylating energy wasting was reduced
by CAT-induced inhibition of ANT. Finally, non-phosphorylating energy wasting was increased in cardiolipin-
enriched mitochondria with substrates for complexes 1 and 2, but not for complex 4. In conclusion, increased
energy wasting measured in liver mitochondria from rats with cancer cachexia is dependent on cardiolipin but
independent of ANT. Interactions between ANT and cardiolipin are modiﬁed when cancer cachexia occurs.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
A large number of cancer patients suffer from cancer-induced ca-
chexia, a complex andmultifactorial metabolic syndrome characterized
by weight loss (depletion of muscle with or without loss of adipose tis-
sues). Cancer cachexia provokes a severe reduction in autonomy andA–FAF, bovine serumalbumin–
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ervais),quality of life and also markedly increases chemotherapy toxicity and
therefore decreases patient survival [1,2]. This poor nutritional status
is also responsible for 20% of deaths per se (immobility, cardiac and re-
spiratory failure) in cancer patients [3]. Treatment is therefore needed
to improve quality of life and reduce mortality. However, the precise
molecular biology mechanisms involved in cancer cachexia remain to
be determined [4].
In cancer patients, such weight loss is characterized by a negative
energy balance due partly to increased whole body energy expenditure
[4]. The liver, a highly metabolic and energy-demanding organ [5],
might be involved in the increased energy expenditure associated
with cancer cachexia. First, liver mass and resting energy expenditure
are increased in cachectic patients with advanced colorectal cancer
[6]. Secondly, the energy metabolism of liver mitochondria is impaired
in several rodentmodels of cancer cachexia [7–9]. Thirdly, we previous-
ly demonstrated a signiﬁcant decrease in the efﬁciency of ATP synthesis
taking place in the liver mitochondria in a rat model of peritoneal
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tochondria of cachectic rats need to consume more nutrients than liver
mitochondria of healthy rats to maintain a satisfactory level of ATP
synthesis.
The ATP required by respiring cells is mainly produced bymitochon-
drial oxidative phosphorylation [5]. In this process, phosphorylation of
ADP to ATP by F1F0ATPase is coupled to oxygen consumption, providing
the ﬁnal reductor of nutrients in the mitochondrial respiratory chain.
However, the coupling (i.e. the efﬁciency of ATP synthesis) is not per-
fect, and some of the energy potential of nutrients is dissipated as heat
instead of being converted into ATP. Such energy wasting is inversely
correlated with the efﬁciency of ATP synthesis but positively correlated
with the quantity of nutrients used to satisfy the demands of ATP.
We found that the reduced efﬁciency of ATP synthesis measured in
liver mitochondria of rats with cancer cachexia was correlated with an
increase in cardiolipin (a speciﬁc phospholipid of the mitochondrial
inner membrane) content (+55%, R2 = 0.64, p b 0.05) [10]. The liver-
speciﬁc energy wasting associated with increased energy expenditure
during cancer cachexia may thus partly be explained by changes in
quantity of cardiolipin and molecular species [10].
Cardiolipin plays a critical role in the normal structure and function
of the adenine nucleotide translocator (ANT) [11] and it has been hy-
pothesized that ANT might represent a downstream target of patholog-
ical states involving changes in cardiolipin metabolism [12]. ANT is an
important component of the mitochondrial machinery of ATP synthesis
because of its intrinsic activity of transporting ADP/ATP across the inner
membrane. Such transport is energy costly due to the associated partial
collapse of the electrochemical gradient established by the electron
transport chain [13]. In addition, ANT is involved in both basal and
fatty acid-induced non-phosphorylating energy-wasting processes
[14,15]. ANT may also be involved in energy wasting as reported in a
model of weight loss induced by glucocorticoid treatment [16]. Wheth-
er ANT could play such a role in the speciﬁc situation of weight loss as-
sociated with cancer cachexia required exploration.
The study reported here was therefore carried out to investigate
the involvement of ANT in energywasting observed in isolated livermi-
tochondria from rats suffering from cancer cachexia induced by PC.
Complementary experiments were performed to study the potential
functional interaction between ANT and cardiolipin in isolated liver mi-
tochondria exposed to cardiolipin-enriched liposomes.
2. Materials and methods
2.1. Experimental design
The study was performed in accordance with the French guidelines
for the care and use of animals and was approved by the local Ethics
Committee (“Comité d'Ethique en Expérimentation Animale Centre
Val de Loire”) (Authorization #2010-34). Cancer cachexia experiment:
rats (healthy immunocompetent Berlin-Druckrey IX, Charles River,
L'Arbresle, France) were divided into 2 groups as previously described
[10]: i) a peritoneal carcinosis group (PC; n = 6), fed ad libitum,
which received a single intraperitoneal (IP) injection of 106 of PROb
cells in 1 ml of culture medium and ii) a control group (n = 6) in
which rats weight-matched to PC rats received an IP injection of 1 ml
of culture medium without PROb cells. Control rats were pair-fed
(each rat from the control group was paired with a rat from the PC
group) in order to discriminate between the effects of anorexia and PC
on the parameters measured in this study. Body weight, food intake,
behaviour and physical appearance were recorded every other day. PC
rats were sacriﬁced at an advanced state of cachexia (severe anorexia
apparent, signiﬁcant loss of skeletal muscle mass and of perirenal
white adipose tissue mass in comparison to control rats) as previously
described [17]. Livers were rapidly removed after sacriﬁce and mito-
chondria were isolated as previously described [10]. Cardiolipin enrich-
ment experiment: one batch of isolated liver mitochondria (fromhealthy Sprague–Dawley, Charles River, L'Arbresle, France) was sepa-
rated into 4 groups: i) untreated mitochondria (M-control) and mito-
chondria treated with ii) carboxyatractylate (CAT), a speciﬁc inhibitor
of ANT (M-CAT), iii) cardiolipin (M-CL) and iv) phosphatidylethanol-
amine (M-PE).
2.2. Preparation of liver mitochondria
Livers were rapidly removed after sacriﬁce and mitochondria were
isolated by differential centrifugation in an ice-cold isolation medium
(250mMsucrose, 1mMEGTAand 20mMTris/HCl, pH 7.4) [10]. Protein
concentration was determined using the Bicinchoninic Acid Assay kit
(Interchim, France).
2.3. Mitochondrial oxygen consumption
Oxygen was measured using a Clark oxygen electrode (Oxygraph,
Hansatech, France). Mitochondria (0.5 mg of protein/ml) were incubat-
ed in a respiratory reaction medium at 37 °C, consisting of 120mMKCl,
5mMKH2PO4, 1mMEGTA, 2mMMgCl2, and 3mMHepes (pH7.4) sup-
plemented with 0.3% (w/v) BSA–FAF, and saturated with room air. The
substrate and inhibitor concentrationswere 5mMsuccinate and 2.5 μM
rotenone, respectively. The ATP synthesis-related oxygen consumption
was initiated by the addition of 300 μM ADP. The non-phosphorylating
oxygen consumption was obtained by the addition of oligomycin
(2 μg/mg of protein).
2.4. Measurement of functional ANT content
Functional ANT content was determined by titrating ATP synthesis-
related oxygen consumptionwith increasing non-saturating concentra-
tions of CAT [18]. Themitochondrial content of ANTwas determined by
extrapolating the linear part of the titration curve to obtain the
amount of CAT required to inhibit ATP synthesis-related oxygen con-
sumption completely. The experimental conditions were: mitochon-
dria (1 mg protein/ml), succinate (5 mM), rotenone (2.5 μM), ADP
(1.5 mM), 0.3% (w/v) BSA–FAF and 37 °C.
2.5. Efﬁciency of ATP synthesis by mitochondria
The kinetic response of oxygen consumption to changes in ATP syn-
thesis was determined at 37 °C in a respiratory reaction medium
(120 mM KCl, 5 mM KH2PO4, 1 mM EGTA, 2 mM MgCl2, 3 mM Hepes,
pH 7.4) supplemented with 0.3% (w/v) bovine serum albumin, and sat-
urated with room air [10]. The experimental conditions were: mito-
chondria (1 mg protein/ml), succinate (5 mM), rotenone (2.5 μM),
glucose (20mM) andATP (125 μM). The rate of ATP synthesiswasmod-
ulated and followed by glucose 6-phosphate accumulation using anADP
regenerating system based on hexokinase (0–0.5 U) plus glucose and
ATP. Oxygen was concomitantly measured by oxygraphy (Hansatech,
France). To test the involvement of ANT, CAT was added at a non-
saturating concentration (100 pmol/mg of protein) in some experi-
ments. This dose is able to inhibit ATP synthesis-related oxygen
consumption to about 16 ± 1%.
2.6. Non-phosphorylating energy wasting by mitochondria
The kinetic response of oxygen consumption in response to a varia-
tion in membrane potential in non-phosphorylating conditions (with-
out ATP synthesis) was determined as previously described [19]. The
experimental conditions were: mitochondria (0.5 mg protein/ml), suc-
cinate (5 mM), rotenone (2.5 μM), oligomycin (2 μg/mg mitochondrial
protein), 0.3% (w/v) BSA–FAF, nigericin (80 ng/ml) and 37 °C.
A saturating concentration of CAT (2 μM) was used to test the in-
volvement of ANT in non-phosphorylating energy wasting. To test the
effects of fatty acids on non-phosphorylating oxygen consumption,
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mitochondria. This concentration of palmitate was not physiological
but, due to the presence of 0.3% BSA–FAF in the respiratory reaction
medium, it was necessary to induce a signiﬁcant increase (30%) in
non-phosphorylating oxygen consumption. The contribution of ANT to
palmitate-induced energy wasting was assessed by measuring the ef-
fects of CAT (2 μM) on palmitate-stimulated oxygen consumption.
To test the nature of the respiratory substrate onnon-phosphorylating
oxygen consumption, glutamate+ malate (5mMand2.5mM), then suc-
cinate (5 mM), then antimycine A (2 μM)+ ascorbate (5 mM) + TMPD
(400 μM) were added sequentially.
2.7. Enrichment in cardiolipin or phosphoethanolamine
Phospholipids were incorporated in liposome membranes to allow
enrichment of liver mitochondrial membranes. As previously described
[20], liposomeswere prepared by sonicating 1.4mgof cardiolipin (com-
posed of 98%18:2 n−6, Sigma, St Quentin Fallavier, France) or 0.5mgof
phosphoethanolamine (Sigma, St Quentin Fallavier, France) in 1 ml of
isolation medium with the microtip probe of a Vibra Cell soniﬁer
(mod. 75022; Bioblock, France) at 40 W for 3 cycles of 2.5 min in an
ice bath under N2 stream. Mitochondria (2 mg) were incubated with
freshly sonicated liposomes (1 ml) at 30 °C for 8 min with constant
stirring to prepare liposome–mitochondrial membrane fusion. After in-
cubation, phospholipid-enriched mitochondria were centrifuged at
10,000 g for 10min to remove excess liposomes. Themitochondrial pel-
let was thenwashed and resuspended in an isolationmedium. The abil-
ity of exogenous fused cardiolipin to reach the inner mitochondrial
membrane was previously described in a study using a similar protocol
to enrichmitochondria with cardiolipin [21] and checked in two exper-
iments in the present article. Brieﬂy, aliquots of mitochondria were
treated with digitonin (0.3 mg/mg mitochondrial protein) to remove
the outer mitochondrial membrane. After incubation in ice for 15 min,
the sample was diluted tenfold and centrifuged at 10,000 g for 10 min.
The resulting mitoplast was resuspended in isolation medium and
cardiolipin content was measured. In two independent experiments,
we conﬁrmed that part of exogenous fused cardiolipin is localized in
the innermitochondrial membranewith the enrichment protocol used.
2.8. Cardiolipin content
Cardiolipin content was measured by using 10-N-nonyl acridine
orange (NAO) as previously described [10]. In pilot studies, the NAO
method has been comparedwithHigh Performance Thin Layer Chroma-
tography (HPTLC)–densitometry and in our experimental andmethod-
ological conditions, quantitation of cardiolipin by these two methods
was comparable.
2.9. Phosphatidylethanolamine content
Phosphatidylethanolamine (PE) contentwas determined by HPTLC–
densitometry. Total lipids were extracted according to the method of
Bligh and Dyer [22]. PE was separated by High Performance Thin Layer
Chromatography thickness (mobile phase: chloroform–acetone–acetic
acid–methanol–water 6:8:2:2:1 (v:v)). After migration, HPTLC plates
were dried for 90 min under a ventilated hood. They were then
immersed for 1 min in a revealing solution (0.18% copper sulphate in
0.7 M orthophosphoric acid) and dried at room temperature. Spots
were then obtained by carbonization (TLC Heater 3, Camag, Muttenz,
Switzerland) and quantiﬁcation was performed using a Reprostar
using WinCats software version 1.4 (Camag, Muttenz, Switzerland).
After preliminary screening, the amount of compound in the sample
was measured and the standard concentrations were adjusted to fall
within in the curve. Images of standards and samples were taken in Rt
mode and transferred to Videoscan software version 1.2 (Camag,
Muttenz, Switzerland).2.10. Statistical analysis
Resultswere expressed asmean±SEM. Differences between groups
were analyzed by Mann–Whitney test for non-paired results or
Wilcoxon signed-ranked test for two related samples. p b 0.05was con-
sidered to be statistically signiﬁcant.
3. Results
3.1. The lower functional ANT content measured in liver mitochondria from
PC rats was without any effects on the efﬁciency of ATP synthesis
A lower CAT concentration was required to fully inhibit ATP
synthesis-related oxygen consumption in liver mitochondria from PC
rats compared to control rats (Fig. 1A). Functional ANT content was re-
duced in liver mitochondria from PC rats by 17± 2%, (p b 0.05; Fig. 1B).
On the basis of the results presented in Fig. 1A, we calculated that
100 pmol of CAT (permg ofmitochondrial protein)was necessary to re-
produce such a decrease in ANT activity. ATP synthesis-related oxygen
consumption of liver mitochondria incubated with 100 pmol of CAT
(M-CAT) was decreased by 16 ± 1% compared to mitochondria not
incubated with CAT (M-control) (p b 0.05; Fig. 1C). However, the efﬁ-
ciency of ATP synthesis was similar betweenM-control andM-CAT con-
ditions (Fig. 1D). These results indicated that ATP synthesis-related
energy wasting was unaffected by such a decrease in ANT activity.
3.2. ANT was not involved in the increase in non-phosphorylating energy
wasting observed in PC rats
As shown in Fig. 2A, oxygen consumption and membrane potential
in non-phosphorylating conditions were insensitive to saturating con-
centrations of CAT (i.e. non-phosphorylating energy wasting was not
decreased by CAT) in both PC and control rats. A role for ANT in the in-
crease in basal non-phosphorylating energy wasting observed in liver
mitochondria from PC rats can therefore be excluded [10].
Since cancer cachexia is associated with increased lipolysis, the
delivery of fatty acids to the liver is increased. Fatty acids are known
to uncouple ATP synthesis by stimulating energy wasting, which is
partly mediated by ANT. In order to mimic this effect in isolated liver
mitochondria we used 200 μM of palmitate. This concentration of
palmitate was able to stimulate oxygen consumption both in non-
phosphorylating and phosphorylating (ATP synthesis) conditions to
the same extent in control and PC rats (p b 0.05; Fig. 2B). It is of note
that these effects of palmitate were reversible since the addition of
BSA–FAFwas able to decrease palmitate-stimulated oxygen consumption
in liver mitochondria from both control and PC rats (data not shown).
Palmitate-induced energy wasting-related oxygen consumption was de-
creased byCAT in control (46±3vs43±3 natoms O/minpermgof pro-
tein, before and after CAT addition, respectively; p b 0.05) but not in PC
rats (41 ± 4 vs 40 ± 4 natoms O/min per mg of protein, before and
after CAT addition, respectively). This suggests that ANTwas not involved
in the fatty acid-induced energy wasting in liver mitochondria from PC
rats.
3.3. Increasing mitochondrial cardiolipin content reduced the efﬁciency of
ATP synthesis, thus mimicking mitochondria of PC rats
Cardiolipin, which is increased in PC rats [10], plays a critical role in
the structure and function of ANT [11]. In order to test the functional
relationship between ANT and cardiolipin, we ﬁrst evaluated the effects
of cardiolipin enrichment on energy wasting. This was performed on
liver mitochondria isolated from healthy rats exposed to cardiolipin-
enriched liposomes.
The cardiolipin content of livermitochondria exposed to cardiolipin-
enriched liposomes was signiﬁcantly increased (+84 ± 6%, p b 0.05)
(Fig. 3A). The linear relationship between oxygen consumption and
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Fig. 1. Effects of cancer cachexia on activity of adenine nucleotide translocase (ANT) in isolated rat liver mitochondria. (A) Determination of functional ANT content by titration of oxygen
consumption related to ATP synthesis with carboxyatractylate (CAT). Measurements were conducted in isolated liver mitochondria from peritoneal carcinosis (PC) rats and control rats.
Control rats were pair-fedwith PC rats. Values expressed asmean± SEM, four animals per group. PC rats= black triangles, control rats= white diamonds. Horizontal lines indicate non-
phosphorylating oxygen consumption values. Vertical arrows indicate the intercept of the regression linewith the respective value of non-phosphorylating oxygen consumption deﬁning
the amount of CAT required for complete inhibition of ATP synthesis-related oxygen consumption. (B) Functional ANT content. Individual ANT content levels were determined on each
mitochondrial preparation by extrapolation of the linear part of the titration curve, as shown in (A). (C) Oxygen consumption related to ATP synthesis for isolated liver mitochondria
from healthy rats incubated with a non-saturating concentration of CAT (100 pmol/mg of protein) (M-CAT) and (M-control) incubated without CAT (n = 5). As shown in A, a dose of
100 pmol of CAT (per mg of protein) was necessary to reproduce the decrease in ANT activity observed in B. (D) Relationship between ATP synthesis rate and oxygen consumption
rate for isolated liver mitochondria from healthy rats incubated with a non-saturating concentration of CAT (100 pmol/mg of protein) (M-CAT) and incubated without CAT (M-control).
ATP synthesis was stimulated by sequential increases in hexokinase concentrations (n = 4; M-control = white squares and M-CAT = black circles).
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the M-control group (Fig. 3B). The intercepts of the regression line were
different between the two groups (49 ± 2 vs 56 ± 3 in M-control and
M-CL groups, respectively) (p b 0.05). The slopes of the regression lines
werenot different (2.9±0.3 vs 2.3±0.3 in control andCL groups, respec-
tively). Thus, for a given ATP synthesis rate, oxygen consumption was
signiﬁcantly higher in cardiolipin-enriched mitochondria than in control
mitochondria, in agreement with previously published in vivo ﬁndings
[10]. In contrast, enrichment of the mitochondrial membrane with
phosphatidylethanolamine, in a range similar to that of cardiolipin
(+81 ± 49%), did not affect the efﬁciency of ATP synthesis (Fig. 3C).
The increased cardiolipin content was also associated with a signiﬁcant
increase in non-phosphorylating energy wasting since oxygen consump-
tion dedicated to processes unrelated to ATP synthesis was increased
(+11 ± 2%; p b 0.05) (Fig. 3D) although membrane potential was not
signiﬁcantly modiﬁed in mitochondria enriched in cardiolipin (Fig. 3E).
3.4. Cardiolipin enrichment did notmodify the functional ANT content but it
did induce non-phosphorylating energy wasting partly mediated by ANT
As shown in Fig. 4A, the same concentration of CAT was required to
fully inhibit ATP synthesis-related oxygen consumption in cardiolipin-
enriched and control mitochondria. Functional ANT content was there-
fore not different between M-CL and M-control mitochondria (Fig. 4B).We also evaluated the role played by ANT in the non-phosphorylating
energy wasting induced by cardiolipin enrichment. As shown in Fig. 4C,
non-phosphorylating oxygen consumption was signiﬁcantly reduced by
saturating concentrations of CAT in cardiolipin-enriched mitochon-
dria (−46 ± 10%; p b 0.05) but not in control mitochondria. This
means that CAT partly counteracted the effects of cardiolipin on
non-phosphorylating oxygen consumption. Non-phosphorylating ener-
gy wasting induced by cardiolipin enrichmentwas therefore partly me-
diated by ANT.
3.5. The nature of the respiratory chain substrate affected non-
phosphorylating energy wasting induced by cardiolipin
Wealso testedwhether thenon-phosphorylating energywasting in-
duced by cardiolipin was dependent on the nature of the respiratory
chain substrates or not. Non-phosphorylating oxygen consumption
was measured with substrates for complex 1 (glutamate/malate), for
complexes 1 + 2 (glutamate/malate + succinate) and for complex
4 (TMPD/ascorbate). We found that the energy wasting induced
by cardiolipin enrichment was detectable for complex 1 (+36 ± 10%;
p b 0.05) and complexes 1 + 2 (+21 ± 2%; p b 0.05) but not for com-
plex 4 (Fig. 4D). As shown in Fig. 3D, energy wasting was increased for
complex 2 (+11± 2%; p b 0.05). Non-phosphorylating energywasting
induced by cardiolipin enrichment was therefore dependent on the
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Fig. 2. Effects of carboxyatractylate (CAT) and palmitate on energy wasting measured in
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substrate for complex 4.4. Discussion
Because of its poor prognosis, a better understanding of cancer ca-
chexia is needed to envisage how to treat it. This studyprovides detailed
information on the involvement of ANT and its interactions with
cardiolipin in cancer cachexia-induced hepatic mitochondrial energy
wasting in rats.The translocation of ATP against ADP is costly energy-wise due to the
partial collapse of the electrochemical gradient established by the elec-
tron transport chain [13]. However, our ﬁndings suggest that the
decrease in functional ANT content observed in rats suffering from can-
cer cachexia has no effect on the energy required to drive ATP synthesis.
Indeed, the efﬁciency of ATP synthesis was unaffected when mitochon-
dria were treated with non-saturating concentrations of CAT, a potent
inhibitor of ANT (in order to reproduce the decrease in functional ANT
observed in PC rats;−16%). ANT is also involved in energy-wastingpro-
cesses not linked to the ADP/ATP exchange. For instance, it has been
suggested that ANT may be involved in non-phosphorylating energy
wasting observed in a model of glucocorticoid-induced weight loss
[16]. ANT has been reported to be involved in both basal and fatty
acid-induced non-phosphorylating energy-wasting processes [14,15].
In the present study, we found that neither basal non-phosphorylating
energy wasting nor palmitate-induced non-phosphorylating energy
wasting was decreased by the addition of saturating concentrations of
CAT in liver mitochondria from PC rats. A role for ANT in basal and
fatty acid-induced non-phosphorylating energy wasting therefore
seems unlikely.
In contrast, and as previously described by others [23], we found that
CATwas able partly to inhibit the fatty acid-inducednon-phosphorylating
energy wasting in liver mitochondria from control rats. Since we have
previously described differences in the cardiolipin content of liver mito-
chondria between PC and control rats [10], we examined the functional
interaction between ANT and cardiolipin in isolated liver mitochondria
exposed to cardiolipin-enriched liposomes. Indeed, cardiolipin canmodi-
fy the activity of several mitochondrial proteins such as complex 1,
complex 3 and ANT [11,24]. In isolated liver mitochondria enriched
in cardiolipin, saturating concentrations of CAT reduced non-
phosphorylating energy wasting while the quantity of functional
ANT (ADP/ATP carrier)was notmodiﬁed. In contrast, in livermitochon-
dria from PC rats in which cardiolipin content had been increased [10],
non-phosphorylating energy wasting was not decreased by saturating
concentrations of CAT and the functional ANT content was reduced. It
seems therefore that the ADP/ATP carrier and energy wasting-related
functions of ANT are regulated differently and that the interactions be-
tween ANT and cardiolipin in liver mitochondria are different in physi-
ologic and pathologic conditions.
In particular, in isolated liver mitochondria exposed to cardiolipin-
enriched liposomes, we observed both an increase in non-
phosphorylating energy wasting and a decrease in the efﬁciency of
ATP synthesis, supporting previously reported results [25]. The addition
of comparable quantities of exogenous phosphatidylethanolamine,
which shares with cardiolipin a common conical shape, did not result
in similar effects. It should be emphasized that 88% of the fatty acids
composing the exogenously-added cardiolipin were linoleic acid, and
that linoleic acid has been found to represent only 38% of the fatty
acids of the cardiolipin extracted from liver mitochondria of cancer ca-
chectic rats [10]. Thus, and as already shown [10,26], changes in fatty
acid composition of cardiolipin might also explain the difference in efﬁ-
ciency of ATP synthesis between PC and control rats. The possibility that
the difference in ANT/cardiolipin interactions observed between liver
mitochondria from PC rats and mitochondria exposed to cardiolipin-
enriched liposomes was due to differences in fatty acid composition
cannot therefore be excluded. However, the role of the fatty acid com-
position of cardiolipin in the interaction between ANT and cardiolipin
is debatable [27]. It has been suggested that, by interacting with ANT,
peroxidized cardiolipin might destabilize the correct conformation of
this protein [28]. It cannot be excluded that the changes in the interac-
tion between ANT and cardiolipin observed in liver mitochondria
during cancer cachexia were due to an increase in cardiolipin peroxida-
tion, since production of reactive oxygen species is raised in this disease
[10]. Finally, in addition to cardiolipin, we have also previously mea-
sured the content of phosphatidylinositol, phosphatidylethanolamine,
phosphatidylcholine and sphingomyelin in liver mitochondria of PC
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Fig. 3. Effects of cardiolipin enrichment on bioenergetic parameters in isolated rat liver mitochondria. Measurements were conducted in liver mitochondria isolated from healthy rats
enriched in vitro with cardiolipin (M-CL), phosphatidylethanolamine (M-PE) or not enriched (M-control). Values expressed as mean ± SEM. (A) Cardiolipin content (n = 9).
(B) Relationship betweenATP synthesis rate and oxygen consumption rate for cardiolipin enrichment. ATP synthesiswas stimulated by a sequential increase inhexokinase concentrations
(n=9;M-control= white squares andM-CL= black diamonds). (C) Relationship between ATP synthesis rate and oxygen consumption rate for phosphatidylethanolamine enrichment.
ATP synthesis was stimulated by sequential increase in hexokinase concentrations (n= 7;M-control = white squares and M-PE= black circles). (D) Oxygen consumption rate in non-
phosphorylating conditions (n 7). (E) Relationship between oxygen consumption and membrane potential (ΔΨ) in non-phosphorylating conditions. Titration was performed with
malonate (n = 5; M-control = white squares and M-CL = black diamonds).
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the contents of phosphatidylinositol and sphingomyelin were higher
in liver mitochondria of PC rats than those in liver mitochondria
of control rats. Contrary to cardiolipin, phosphatidylinositol and
sphingomyelin contents were not correlated to energy wasting. To
our knowledge, whether phosphatidylinositol or sphingomyelin is
able to modify the energy-wasting processes dependent of ANT is
outside of themajor aim of the present study and is in need of further
study.
In addition to ANT, we also studied the involvement of the nature of
the respiratory chain substrates in non-phosphorylating energywastinginduced by cardiolipin. We found that non-phosphorylating energy
wasting was higher in cardiolipin-enrichedmitochondria with substrates
for complexes 1, 1+ 2 and 2 than in control mitochondria, but not with a
substrate for complex 4. This suggests that cardiolipin enrichment acted
preferentially on the proton-pump efﬁciency (H+/2e− stoichiometry) of
complexes 1 and/or 3. Moreover, the intensity of energy wasting was
higher for respiratory chain complex 1 substrate (carbohydrate) than
for complex 2 (fatty acids). This difference in substrate has interesting
implications since liver β-oxidation appeared to be reduced in cancer ca-
chexia, leading to the use of complex 1-related substrate for ATP produc-
tion [29], and this requires exploration.
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Our ﬁndings demonstrate that the interactions between ANT and
cardiolipin in liver mitochondria are modiﬁed by cancer cachexia. We
found that ANT was not involved in the increased energy wasting ob-
served in liver mitochondria from cancer cachectic rats. Our model of
cardiolipin-enriched liver mitochondria showed for the ﬁrst time direct
causality between the increase in mitochondrial membrane cardiolipin
content and reduction in efﬁciency of ATP synthesis, supporting the
involvement of cardiolipin in the mitochondrial energy wasting associ-
ated with cancer cachexia. Interestingly, energy wasting processes
involved in the decreased efﬁciency of ATP synthesis induced by
cardiolipin depended on the nature of the respiratory chain substrates.
These mechanistic ﬁndings provide new insights into the molecular
changes occurring in liver mitochondria of rats with cachexia but also
with other disorders in which cardiolipin is critical.Acknowledgements
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